Marriott (MAR) Q2 2026 (USD): Adj. EPS 3.19 (exp 3.08), Cost reimbursement Revenue 7.07bln (exp. 7.19bln)

An earnings beat across EPS, operating income and EBITDA with a miss on the cost reimbursement line fits a pattern familiar in lodging prints: the fee-based franchised model means revenue composition matters less to the equity than margin and fee income, and reimbursement revenue is largely a pass-through that historically carries little signal for the stock's reaction. For asset-light hotel operators, the market has tended to key off adjusted EBITDA and the forward guide on rooms growth and RevPAR rather than the topline aggregates, so the profit-line beats here are the operative takeaway. Marriott has in past quarters traded on the quality of its guidance and any update to net rooms growth and fee assumptions more than on the quarter itself, and the follow-on of consequence is the commentary on international demand, particularly the China and Asia-Pacific recovery trajectory and US select-service softness versus luxury resilience. Peers in the lodging complex have typically moved in sympathy on the RevPAR and pipeline read-across, with the group re-rating or de-rating together on the demand narrative rather than on a single operator's cost line. The call and the full-year outlook, including any change to buyback or capital return pacing, are where precedent suggests the durable move gets made.